Literature DB >> 25050923

The role of T cells in systemic lupus erythematosus: an update.

Christine Konya1, Ziv Paz, George C Tsokos.   

Abstract

PURPOSE OF REVIEW: To describe our current understanding of the role of T cells in the pathophysiology of systemic lupus erythematosus (SLE). RECENT
FINDINGS: Over the last few years, the dominant role of T cells in autoimmunity and SLE was established. Genome-wide-association studies led to the discovery of multiple single-nucleotide polymorphisms associated with SLE. Most of these single-nucleotide polymorphisms fall within the noncoding DNA regions of immune response-related genes and few seem to contribute to the observed abnormal T cell function. The field of epigenetics research developed rapidly and provided us with new insights into the observed generalized hypomethylation in SLE T cells, the abnormal histone modifications and the role of RNA interference. Old observations, such as the decreased interleukin-2 production, are better understood with our evolved knowledge of many signal transduction pathways and the way they converge and regulate the transcription of different genes in T cells. Finally, we are now able to identify subpopulations of T cells, such as Th17 and T regulatory cells, and to define their role in SLE.
SUMMARY: T cells are key players in SLE, and over the last few years our understanding of their activation, signal transduction and gene regulation has evolved significantly.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25050923     DOI: 10.1097/BOR.0000000000000082

Source DB:  PubMed          Journal:  Curr Opin Rheumatol        ISSN: 1040-8711            Impact factor:   5.006


  19 in total

Review 1.  Calcium Signaling: From Normal B Cell Development to Tolerance Breakdown and Autoimmunity.

Authors:  Patrice Hemon; Yves Renaudineau; Marjolaine Debant; Nelig Le Goux; Sreya Mukherjee; Wesley Brooks; Olivier Mignen
Journal:  Clin Rev Allergy Immunol       Date:  2017-10       Impact factor: 8.667

2.  Association of interleukin-10 promoter haplotypes with disease susceptibility and IL-10 levels in Mexican patients with systemic lupus erythematosus.

Authors:  Claudia Azucena Palafox-Sánchez; Edith Oregon-Romero; Diana Celeste Salazar-Camarena; Yeminia Maribel Valle; Jesús René Machado-Contreras; Alvaro Cruz; Mariana Orozco-López; Gerardo Orozco-Barocio; Mónica Vázquez-Del Mercado; José Francisco Muñoz-Valle
Journal:  Clin Exp Med       Date:  2014-09-25       Impact factor: 3.984

Review 3.  T cells and IL-17 in lupus nephritis.

Authors:  Tomohiro Koga; Kunihiro Ichinose; George C Tsokos
Journal:  Clin Immunol       Date:  2016-04-21       Impact factor: 3.969

Review 4.  Metabolic Factors that Contribute to Lupus Pathogenesis.

Authors:  Wei Li; Ramya Sivakumar; Anton A Titov; Seung-Chul Choi; Laurence Morel
Journal:  Crit Rev Immunol       Date:  2016       Impact factor: 2.214

Review 5.  Antigen-specific immunotherapies in rheumatic diseases.

Authors:  Judit Pozsgay; Zoltán Szekanecz; Gabriella Sármay
Journal:  Nat Rev Rheumatol       Date:  2017-07-13       Impact factor: 20.543

6.  Retinal thickness and microvascular alterations in the diagnosis of systemic lupus erythematosus: a new approach.

Authors:  Ren Liu; Yan Wang; Qiang Xia; Tian Xu; Ting Han; Shuang Cai; Shui-Lin Luo; Rui Wu; Yi Shao
Journal:  Quant Imaging Med Surg       Date:  2022-01

7.  Inhibition of SHP2 ameliorates the pathogenesis of systemic lupus erythematosus.

Authors:  Jianxun Wang; Masayuki Mizui; Li-Fan Zeng; Roderick Bronson; Michele Finnell; Cox Terhorst; Vasileios C Kyttaris; George C Tsokos; Zhong-Yin Zhang; Maria I Kontaridis
Journal:  J Clin Invest       Date:  2016-05-16       Impact factor: 14.808

8.  Suppression of interleukin 17 contributes to the immunomodulatory effects of adipose-derived stem cells in a murine model of systemic lupus erythematosus.

Authors:  Xiaoliang He; Yunlong Zhang; Ai Zhu; Kang Zeng; Xiuping Zhang; Li Gong; Yusheng Peng; Kuan Lai; Shaogang Qu
Journal:  Immunol Res       Date:  2016-12       Impact factor: 2.829

9.  Long-term effects of tacrolimus for maintenance therapy of lupus nephritis: a 5-year retrospective study at a single center.

Authors:  Kazunori Karasawa; Keiko Uchida; Mio Kodama; Takahito Moriyama; Kosaku Nitta
Journal:  Rheumatol Int       Date:  2018-09-10       Impact factor: 2.631

10.  JAK2 and PTPRC mRNA expression in peripheral blood mononuclear cells from patients with systemic lupus erythematosus.

Authors:  Danfeng Qian; Lu Liu; Tingting Zhu; Leilei Wen; Zhengwei Zhu; Xianyong Yin; Ying Qiu; Mingshun Wu; Xueying Li; Jie Ma; Qun Zhang; Ling Jin; Xiaomeng Wang; Qiaohu Xu; Sen Yang; Yujun Sheng; Shengquan Zhang; Xuejun Zhang
Journal:  Clin Rheumatol       Date:  2019-11-23       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.